TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVANYSEPharmaceutical PreparationsUS미국
30일 공시 수
3건
최근 2026.11.02
90일 내부자 순매수
-205억원
순매도
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 10건
- US미국대량보유(5%)중요도 낮음어제정정SCHEDULE 13G/A · Beneficial ownership report (13G)
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
SCHEDULE 13G/A · 2026.11.02 20:17 KST
- US미국지배구조·주총중요도 보통4일 전8-K · Current report (Items 5.02)
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
8-K · 2026.10.30 06:08 KST
- US미국임원·주요주주 소유중요도 낮음2026.10.083 · Initial statement of beneficial ownership
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
Form 3 · 2026.10.08
- US미국임원·주요주주 소유중요도 보통2026.09.224 · Statement of changes in beneficial ownership
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
Form 4 · 2026.09.22
- US미국임원·주요주주 소유중요도 높음2026.09.224 · Statement of changes in beneficial ownership
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
Form 4 · 2026.09.22
- US미국주요사항·수시공시중요도 높음2026.09.178-K · Current report (Items 1.01, 2.03, 9.01)
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
8-K · 2026.09.17 05:25 KST
- US미국주요사항·수시공시중요도 낮음2026.09.158-K · Current report (Items 8.01)
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
8-K · 2026.09.15 05:06 KST
- US미국주요사항·수시공시중요도 낮음2026.09.128-K · Current report (Items 7.01, 8.01, 9.01)
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
8-K · 2026.09.12 05:05 KST
- US미국주요사항·수시공시중요도 낮음2026.09.048-K · Current report (Items 8.01, 9.01)
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
8-K · 2026.09.04 05:12 KST
- US미국주요사항·수시공시중요도 낮음2026.09.048-K · Current report (Items 3.03, 9.01)
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
8-K · 2026.09.04 05:06 KST